Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Expert Opinion on Emerging Drugs|August 18, 2011
Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulationsStuart K Pitman, Richard H Drew, John R Perfect
Expert Opinion on Investigational Drugs|July 23, 2004
Novel modes of antifungal drug administrationRebekah R Arthur, Richard H Drew, John R Perfect
Expert Review of Anti-Infective Therapy|March 4, 2009
Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an updateWinter J Smith, Richard H Drew, John R Perfect
International Journal of Clinical Pharmacy|February 1, 2015
Risk factors associated with unfavorable short-term treatment outcome in patients with documented Pseudomonas aeruginosa infectionV Paul DiMondi, Mary L Townsend, Richard H Drew
Expert Review of Anti-Infective Therapy|May 28, 2005
Liposomal amphotericin B: clinical experience and perspectivesWinter J Gibbs, Richard H Drew, John R Perfect
Infection Control and Hospital Epidemiology|March 8, 2013
Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admissionSteven W Johnson, Deverick J Anderson, D Byron May, et al.
Expert Opinion on Pharmacotherapy|February 4, 2003
Antifungal pharmacotherapy for invasive mould infectionsJason C Gallagher, Elizabeth S Dodds Ashley, Richard H Drew, et al.
Medical Mycology|March 4, 2011
Overview of treatment options for invasive fungal infectionsMelanie W Pound, Mary L Townsend, Vincent Dimondi, et al.
Pageof 5